November 15, 2019November 15, 2019

Finch and Takeda Expand Their Collaboration to Target Crohn’s Treatment Development

News

Finch Therapeutics and Takeda Pharmaceutical are joining forces to develop a treatment for Crohn’s disease — expanding their partnership in their development program for inflammatory bowel disease (IBD), which includes an ... Read more

April 6, 2017April 6, 2017

Finch, Takeda to Jointly Develop Microbiome Therapeutic for Ulcerative Colitis

News

Japan’s Takeda Pharmaceutical and Boston-based Finch Therapeutics will jointly develop the drug FIN-524 to treat ulcerative colitis, a form of inflammatory bowel disease (IBD). FIN-524 is Finch’s first microbiotic product candidate. The company says its live biotherapeutic product ... Read more